69 related articles for article (PubMed ID: 180397)
21. Inhibition of tumor growth with a new synthetic ribonucleic acid.
Fisher JC; Cooperband SR; Mannick JA
Surg Forum; 1970; 21():122-4. PubMed ID: 4328378
[No Abstract] [Full Text] [Related]
22. Experimental ocular studies with polyinosinic acid: polycytidylic acid.
McDonald TO
Eye Ear Nose Throat Mon; 1973 Feb; 52(2):45-52. PubMed ID: 4346077
[No Abstract] [Full Text] [Related]
23. Specific immunosuppression, polyinosinic--polycytidylic acid, and viruses in New Zealand mice.
Talal N; Steinberg AD; Gazdar AF
Fed Proc; 1971; 30(6):1842-5. PubMed ID: 4330992
[No Abstract] [Full Text] [Related]
24. The formation of complexes between polynucleotides, carboxymethylcellulose and polylysine which are anti-viral in mice without inducing interferon.
Stebbing N; Dawson KM
Mol Pharmacol; 1979 Jul; 16(1):313-23. PubMed ID: 225654
[No Abstract] [Full Text] [Related]
25. Polyinosinic acid-polycytidylic acid in ophthalmology. I. Ocular irritation studies in rabbits.
McDonald TO; Fox LG; Timberlake GM; Belluscio PR; Borgmann AR
Ann Ophthalmol; 1971 Apr; 3(4):371-6. PubMed ID: 5163962
[No Abstract] [Full Text] [Related]
26. Inhibition of the growth of murine malignant melanoma by polyinosinic-polycytidylic acid.
Bart RS; Kopf AW; Silagi S
J Invest Dermatol; 1971 Jan; 56(1):33-8. PubMed ID: 5556497
[No Abstract] [Full Text] [Related]
27. Protective effect of immunization with polyinosinic-polycytidylic acid complexed with methylated bovine serum albumin against Friend leukemia virus in mice.
Fourcade A; Friend C; Lacour F; Holland JG
Cancer Res; 1974 Jul; 34(7):1749-51. PubMed ID: 4833920
[No Abstract] [Full Text] [Related]
28. Polyinosinic acid-polycytidylic acid and its mismatched analogues: differential effects on human cell function.
O'Malley JA; Leong SS; Horoszewicz JS; Carter WA; Alderfer JL; Ts'o PO
Mol Pharmacol; 1979 Jan; 15(1):165-73. PubMed ID: 423886
[No Abstract] [Full Text] [Related]
29. Variations in the contribution of induced interferon and adjuvanticity to the antiviral effect of different polyinosinic acid . polycytidylic acid formulations in mice infected with encephalomyocarditis virus.
Stebbing N; Lindley IJ; Dawson KM
Infect Immun; 1980 Sep; 29(3):960-5. PubMed ID: 6253403
[TBL] [Abstract][Full Text] [Related]
30. Enhanced biosynthesis of extracellular matrix proteins and TGF-beta 1 by polyinosinic-polycytidylic acid during cutaneous wound healing in vivo.
Sidhu GS; Thaloor D; Singh AK; Raghunath PN; Maheshwari RK
J Cell Physiol; 1996 Oct; 169(1):108-14. PubMed ID: 8841427
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of an interferon inducer in viral respiratory disease.
Hill DA; Baron S; Perkins JC; Worthington M; Van Kirk JE; Mills J; Kapikian AZ; Chanock RM
JAMA; 1972 Feb; 219(9):1179-84. PubMed ID: 4334380
[No Abstract] [Full Text] [Related]
32. Suppressor factors and their potential for immunotherapy, and chemical influences on interferons.
Gainer JH
J Am Vet Med Assoc; 1982 Nov; 181(10):1107-10. PubMed ID: 6184353
[No Abstract] [Full Text] [Related]
33. Interferon mediated antiviral activity against salmonid fish viruses in BF-2 and other cell lines.
Saint-Jean SR; Pérez-Prieto SI
Vet Immunol Immunopathol; 2006 Mar; 110(1-2):1-10. PubMed ID: 16169598
[TBL] [Abstract][Full Text] [Related]
34. [Immunogenic capacity of poly I poly C methylated bovine serum albumin in rabbits, hamsters and mice].
Lacour F; Deleon I; Nahon-Merlin E
Ann Inst Pasteur (Paris); 1971 Nov; 121(5):633-40. PubMed ID: 5003738
[No Abstract] [Full Text] [Related]
35. Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complex.
Kern ER; Olsen GA; Overall JC; Glasgow LA
Antimicrob Agents Chemother; 1978 Feb; 13(2):344-6. PubMed ID: 206203
[TBL] [Abstract][Full Text] [Related]
36. Effect of autoclaving on molecular weight distribution and chemotherapeutic activity of clinical samples of poly IC (NSC-120949).
Coffey JJ; Kelley SA; Wodinsky I
Cancer Chemother Rep; 1972 Feb; 56(1):31-3. PubMed ID: 5030807
[No Abstract] [Full Text] [Related]
37. Prophylactic and therapeutic use of poly(I)-poly(C) (poly-D-lysine) against herpesvirus encephalitis in mice.
Catalano LW; London WT; Rice JM; Sever JL
Proc Soc Exp Biol Med; 1972 May; 140(1):66-71. PubMed ID: 4338187
[No Abstract] [Full Text] [Related]
38. Studies on poly I:C toxicity in experimental animals.
Homan ER; Zendzian RP; Schott LD; Levy HB; Adamson RH
Toxicol Appl Pharmacol; 1972 Dec; 23(4):579-88. PubMed ID: 4630165
[No Abstract] [Full Text] [Related]
39. The influence of Poly I:C on the course of infection in mice inoculated with West Nile virus.
Haahr S
Arch Gesamte Virusforsch; 1971; 35(1):1-9. PubMed ID: 5130442
[No Abstract] [Full Text] [Related]
40. Polyinosinic-cytidylic acid complex (poly I:C) and viral infections in mice.
Lindh HF; Lindsay HL; Mayberry BR; Forbes M
Proc Soc Exp Biol Med; 1969 Oct; 132(1):83-7. PubMed ID: 4310180
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
